SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-23-003856
Filing Date
2023-10-13
Accepted
2023-10-13 17:00:21
Documents
13
Period of Report
2023-10-06
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea186699-8k_pasithea.htm   iXBRL 8-K 28128
  Complete submission text file 0001013762-23-003856.txt   247151

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ktta-20231006.xsd EX-101.SCH 3810
3 XBRL DEFINITION FILE ktta-20231006_def.xml EX-101.DEF 26681
4 XBRL LABEL FILE ktta-20231006_lab.xml EX-101.LAB 36819
5 XBRL PRESENTATION FILE ktta-20231006_pre.xml EX-101.PRE 25305
7 EXTRACTED XBRL INSTANCE DOCUMENT ea186699-8k_pasithea_htm.xml XML 5433
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

IRS No.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40804 | Film No.: 231325583
SIC: 2834 Pharmaceutical Preparations